Roche R&D Model Is Designed To Accelerate Complex Research Organization
This article was originally published in The Pink Sheet Daily
Executive Summary
Global R&D activities will be centered around five Disease Biology Areas: oncology, virology, inflammation, metabolism and CNS.
You may also be interested in...
Roche Global Head Of Pharma Partnering Dan Zabrowski: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Zabrowski’s number one concern? Filling the gap when products go off patent.
Roche Global Head Of Pharma Partnering Dan Zabrowski: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Zabrowski’s number one concern? Filling the gap when products go off patent.
GSK Jumps Into Growing China R&D Space
GlaxoSmithKline has joined a growing list of big pharma companies expanding in China, launching a research and development center based in Shanghai, the company announced May 24